Sirigen develops light harvesting materials delivering high sensitivity fluorescence for the early detection of life threatening diseases.
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces.Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 25, 2011 | Series Unknown | $3M | 1 | — | — | Detail |
Oct 1, 2010 | Series Unknown | £3.83M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
British Smaller Technology Companies VCT 2 | — | Series Unknown |
Persistence Partners | — | Series Unknown |